ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,238Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 13

$917K Total Retail Price of All Prescriptions

Rank: 1 out of 13

534 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

43% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 42%.

Schedule Three
Controlled Substances

46% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 50%.

Risky Drugs to Seniors

1% of this provider’s 2,284 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,458 423 S3 1 1
GABAPENTIN 920 183 2 2
TIZANIDINE HCL 870 147 3 5
OXYCODONE HCL 811 86 S2 4 3
MORPHINE SULFATE ER 468 43 S2 5 4
TRAMADOL HCL 357 88 6 9
OPANA ER 327 14 S2 7 18
MELOXICAM 301 65 8 17
LYRICA 296 42 9 12
OXYCODONE HCL-ACETAMINOPHEN 241 16 S2 10 6
ZOLPIDEM TARTRATE 198 36 11 7
NAPROXEN 180 17 12 24
CYMBALTA 175 51 13 14
OXYCONTIN 174 24 S2 14 8
FENTANYL 154 33 S2 15 11
ENDOCET 150 21 S2 16 13
CYCLOBENZAPRINE HCL 136 0 R 17 15
ZONISAMIDE 99 26 18 32
METHOCARBAMOL 90 0 R 19 19
BACLOFEN 88 0 20 20
NEXIUM 86 21 21 28
METHYLPREDNISOLONE 79 0 22 35
OXYCODONE-ACETAMINOPHEN 77 0 S2 23 30
PROMETHAZINE HCL 73 0 R 24 25
CITALOPRAM HBR 71 15 25 26
SAVELLA 69 0 26 37
CELEBREX 64 28 27 27
OXYMORPHONE HCL 56 0 S2 28 41
AMITRIPTYLINE HCL 56 0 R 28 29
CLONIDINE HCL 52 11 30 31
BUPROPION HCL SR 51 0 31 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.